369 related articles for article (PubMed ID: 2568299)
21. Lack of gastric acid rebound after stopping a successful short-term course of nizatidine in duodenal ulcer patients.
Savarino V; Mela GS; Zentilin P; Sumberaz A; Bonifacino G; Celle G
Am J Gastroenterol; 1991 Mar; 86(3):281-4. PubMed ID: 1671805
[TBL] [Abstract][Full Text] [Related]
22. Single bedtime dose of famotidine: assessment of its antisecretory action by 24-hour intragastric pH monitoring.
Savarino V; Picciotto A; Magnolia MR; Scalabrini P; Mela GS; Celle G
J Clin Pharmacol; 1987 Oct; 27(10):790-3. PubMed ID: 2892864
[TBL] [Abstract][Full Text] [Related]
23. Do ranitidine and nizatidine influence pepsin secretion?
Vianello F; Tessaro P; Di Mario F; Dal Santo PL; Vio A; Plebani M; Burlina A; Naccarato R
Acta Gastroenterol Belg; 1988; 51(2):154-8. PubMed ID: 2906777
[No Abstract] [Full Text] [Related]
24. Reduction of gastric acidity with ranitidine or famotidine: early evening dosage is more effective than late evening dosage.
Bauerfeind P; Cilluffo T; Emde C; Fimmel C; Kohler W; Gasser T; Blum AL
Digestion; 1987; 37(4):217-22. PubMed ID: 2890546
[TBL] [Abstract][Full Text] [Related]
25. Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2 receptor blockade.
Nwokolo CU; Smith JT; Sawyerr AM; Pounder RE
Gut; 1991 Dec; 32(12):1455-60. PubMed ID: 1685465
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the effect of the antacid Rennie versus low-dose H2-receptor antagonists (ranitidine, famotidine) on intragastric acidity.
Netzer P; Brabetz-Höfliger A; Bründler R; Flogerzi B; Hüsler J; Halter F
Aliment Pharmacol Ther; 1998 Apr; 12(4):337-42. PubMed ID: 9690722
[TBL] [Abstract][Full Text] [Related]
27. A single night-time dose of famotidine is equivalent to ranitidine in decreasing 24-hour gastric acidity in asymptomatic duodenal ulcer subjects.
Thomson AB; Pinchbeck BR; Kirdeikis J; Zuk L; Marriage B; Prat A
Aliment Pharmacol Ther; 1989 Apr; 3(2):199-210. PubMed ID: 2491470
[TBL] [Abstract][Full Text] [Related]
28. Gastric and esophageal acidity during continuous treatment with H2-antagonists in uncomplicated esophagitis.
Fiorucci S; Santucci L; Perrone E; Abbritti F; Morelli A
Scand J Gastroenterol; 1989 Aug; 24(6):671-7. PubMed ID: 2573143
[TBL] [Abstract][Full Text] [Related]
29. Famotidine versus ranitidine for the short-term treatment of duodenal ulcer.
Simon B; Dammann HG; Jakob G; Miederer SE; Müller P; Ottenjann R; Paul F; Scholten T; Schütz E; Seifert E
Digestion; 1985; 32 Suppl 1():32-7. PubMed ID: 2866134
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and pharmacodynamics of famotidine and ranitidine in critically ill children.
Madani S; Kauffman R; Simpson P; Lehr VT; Lai ML; Sarniak A; Tolia V
J Clin Pharmacol; 2014 Feb; 54(2):201-5. PubMed ID: 24258773
[TBL] [Abstract][Full Text] [Related]
31. The effect of a single oral morning dose of nizatidine and ranitidine on intragastric pH under basal conditions and after pentagastrin stimulation.
Lazzaroni M; Sangaletti O; Bianchi Porro G
J Int Med Res; 1992 Nov; 20(6):454-60. PubMed ID: 1286739
[TBL] [Abstract][Full Text] [Related]
32. Validation of pH dataloggers for pharmacologic studies.
Chiverton SG; Burget DW; Hunt RH
Scand J Gastroenterol; 1989 Oct; 24(8):975-81. PubMed ID: 2512632
[TBL] [Abstract][Full Text] [Related]
33. Control of intragastric acidity with over-the-counter doses of ranitidine or famotidine.
Hamilton MI; Sercombe J; Pounder RE
Aliment Pharmacol Ther; 2001 Oct; 15(10):1579-83. PubMed ID: 11563997
[TBL] [Abstract][Full Text] [Related]
34. Does smoking interfere with the effect of histamine H2-receptor antagonists on intragastric acidity in man?
Bauerfeind P; Cilluffo T; Fimmel CJ; Emde C; von Ritter C; Kohler W; Gugler R; Gasser T; Blum AL
Gut; 1987 May; 28(5):549-56. PubMed ID: 3596336
[TBL] [Abstract][Full Text] [Related]
35. The effects of low doses of ranitidine on intragastric acidity in healthy men.
Wyeth JW; Pounder RE; Sercombe JC; Snell CC
Aliment Pharmacol Ther; 1998 Mar; 12(3):255-61. PubMed ID: 9570260
[TBL] [Abstract][Full Text] [Related]
36. The effect of an oral morning dose of nizatidine and ranitidine on gastric acid secretion in duodenal ulcer patients.
Lazzaroni M; Bianchi Porro G
Hepatogastroenterology; 1989 Dec; 36(6):490-3. PubMed ID: 2575571
[TBL] [Abstract][Full Text] [Related]
37. [Effect of Famotidine in gastric acidity, plasma secretin and gastrin in duodenal ulcer patients. With reference to 24-hour intragastric pH monitoring].
Shiratori K; Watanabe S; Maruyama M; Itoh Y; Adachi H; Kurokawa K; Takeuchi T
Nihon Shokakibyo Gakkai Zasshi; 1984 Mar; 81(3):855-63. PubMed ID: 6146733
[No Abstract] [Full Text] [Related]
38. [Nizatidine versus ranitidine in the treatment of acute duodenal ulcer. Comparison of 300 mg nizatidine and 300 mg ranitidine in a single evening dose].
Arnold R; Beckenbach P; Bock H; Bormann R; Daake H; Dammann HG; Du Bosque G; Fürer M; Geiter B; Hebbeln H
Fortschr Med; 1989 Jul; 107(21):467-70. PubMed ID: 2570012
[TBL] [Abstract][Full Text] [Related]
39. Determination of the time of onset of action of ranitidine and famotidine on intra-gastric acidity.
Gardner JD; Ciociola AA; Robinson M; McIsaac RL
Aliment Pharmacol Ther; 2002 Jul; 16(7):1317-26. PubMed ID: 12144582
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the effects of ranitidine, cimetidine and placebo on the 24 hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer.
Walt RP; Male PJ; Rawlings J; Hunt RH; Milton-Thompson GJ; Misiewicz JJ
Gut; 1981 Jan; 22(1):49-54. PubMed ID: 6109686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]